HeartFlow IPO
HeartFlow develops AI-powered diagnostic software that creates 3D models of coronary arteries from CT scans to assess heart disease non-invasively. The technology is FDA-cleared and used by hospitals as an alternative to invasive catheterization procedures. HeartFlow has been pursuing a public listing after a previous SPAC deal was canceled.
What We Know
HeartFlow completed its IPO on the Nasdaq under ticker HTFL in August 2025 at $19 per share, raising $364 million. The stock opened at $28, surging over 58% on day one. HeartFlow previously had a SPAC deal that fell through before pursuing a traditional IPO.
Frequently Asked Questions
Has HeartFlow had an IPO?
Yes, HeartFlow has already gone public. The company IPO'd on the Nasdaq under ticker HTFL in August 2025 at $19 per share.
When is the HeartFlow IPO date?
HeartFlow's IPO date was August 11, 2025. The stock opened at $28, surging over 58% above its IPO price on day one.
How can I buy HeartFlow stock?
You can buy HeartFlow stock (HTFL) through any major brokerage account. The company trades on the Nasdaq.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts